SCHEMBL4485387

SCHEMBL4485387

O=C(O)[C@H]1CCCN(C(=O)c2ccccn2)C1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 1/20 0.65
ATG4B Q9Y4P1 1/20 0.65
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.59
EPHX2 P34913 1/20 0.55
PDE10A Q9Y233 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CHRNB2 P17787 1/20 0.52
CHRNB4 P30926 1/20 0.52
CHRNA3 P32297 1/20 0.52
CHRNA7 P36544 1/20 0.52
CHRNA4 P43681 1/20 0.52
PDE2A O00408 1/20 0.51
TP53BP1 Q12888 1/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ALDH1A1 P00352 1/20 0.49
RIPK1 Q13546 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4485391 1.00 PLA2G1B (0.65) PLA2G1BATG4BMEN1KMT2AL3MBTL1
SCHEMBL28448703 0.92 L3MBTL1 (0.62) PLA2G1BATG4BMEN1KMT2AL3MBTL1
SCHEMBL21926837 0.83 MEN1 (0.65) PLA2G1BATG4BMEN1KMT2AL3MBTL1
SCHEMBL4494471 0.83 PLA2G1B (0.47) PLA2G1BATG4BMEN1KMT2ATP53BP1
SCHEMBL14730857 0.82 RECQL (0.62) PLA2G1BATG4BMEN1KMT2AL3MBTL1
SCHEMBL5478237 0.82 PLA2G1B (0.75) PLA2G1BATG4BMEN1KMT2AL3MBTL1
SCHEMBL5478240 0.82 PLA2G1B (0.75) PLA2G1BATG4BMEN1KMT2AL3MBTL1
SCHEMBL5098686 0.82 L3MBTL1 (0.56) PLA2G1BATG4BMEN1KMT2AL3MBTL1
SCHEMBL4491933 0.81 KDM4E (0.58) PLA2G1BATG4BMEN1KMT2ACYP3A4
SCHEMBL4491941 0.81 KDM4E (0.58) PLA2G1BATG4BMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598392-B2 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof SANOFI-AVENTIS (FR) 2009-10-06 US disclosed
US-20070259847-A1 2-Amido-4-phenylthiazole Derivatives, The Preparation And The Therapeutic Use Thereof SANOFI-AVENTIS (FR) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259847-A1 2-Amido-4-phenylthiazole Derivatives, The Preparation And The Therapeutic Use Thereof PKD2, TPMT, PKD1 PLA2G1B 1160/4885ATG4B 873/4885MEN1 2320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.